Molecular Therapy: Oncology
Publisher: Elsevier · ISSN 2950-3299 · 78 articles
- StagX1, an isoquinolinone compound, selectively targets CES1-positive Ewing sarcoma cells as a potential therapeutic agent
- Additive effect of Ruta graveolens bioactive phytoconstituents and cisplatin through PKC/MEK/ERK pathway in glioblastoma
- Ultrasound controllable and antigen-independent killing via cis-activating CAR T cells
- Therapeutic targeting of cancer-associated fibroblasts with oncolytic virus in preclinical models of intrahepatic cholangiocarcinoma
- USP15 regulates mitotic fidelity, metastatic potential, and chemotherapeutic response in ovarian cancer cells
- Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway
- Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety
- A p53R273H-selective bispecific T cell engager: Computational design and functional validation
- Targeting AATF reprograms the tumor microenvironment and suppresses hepatocellular carcinoma via MIR100HG-TGF-β signaling
- Intramuscular plasmid DNA electroporation sequesters neoantigen-specific CD8+ T cells in treated muscle and limits tumor infiltration
- AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer
- Retraction Notice to: Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer
- Retraction Notice to: Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β
- Retraction Notice to: Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition
- An engineered PD-1 receptor-based CAR that binds anti-PD-1 antibodies but not PD-L1 to enhance T-cell functionality
- Multi-level systems analysis identifies XPO1 as a druggable target linked to NFκB activation, tumor clonality and long-term survival in Adult T-cell Leukemia
- CXCR2 enhances the migration-independent efficacy of pan-cancer CAR-T cells
- Novel TCR-T cells targeting WT137-45 demonstrating anti-cancer reactivity
- Impact of sex differences on metronomic chemotherapy efficacy in oral squamous cell carcinoma patients
- Palmitoyl-protein thioesterase 1, PPT1: from a key enzyme driving the autophagy process to a promising target for drug development in cancer
- Statin-driven reversal of Sunitinib resistance through protein prenylation-blockade in clear cell renal cell carcinoma
- Surgical stress-induced hepatic regulatory T cells promote the development of colorectal liver metastases
- Gene therapy as an upcoming technique in the treatment of cancer: A cellular solution to a cellular problem
- Emerging cell therapies for gastrointestinal cancers: Advances and future perspectives
- Overcoming translational and manufacturing barriers of CAR-T cell therapy in the Brazilian landscape
- ATMPs in oncology: A comprehensive review of CAR-T and CIK cell therapies within the European regulatory framework
- Preclinical evaluation of triple-mutated oncolytic herpes virus expressing fusion-type interleukin 12 for malignant melanoma
- Engineering “off-the-shelf” TCR-T cells: A transient mRNA platform for balanced alloreactivity and functionality
- FOXM1 drives cisplatin resistance in ovarian cancer through STIM1-mediated SOCE and STAT1 activation
- A novel spliceosome inhibitor triggers anti-tumor CD4+ and CD8+ T cell responses in murine models of pediatric-relevant cancer